Joong Bok Ahn

435 total citations
9 papers, 375 citations indexed

About

Joong Bok Ahn is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Joong Bok Ahn has authored 9 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Joong Bok Ahn's work include Peroxisome Proliferator-Activated Receptors (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and Synthesis of heterocyclic compounds (2 papers). Joong Bok Ahn is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and Synthesis of heterocyclic compounds (2 papers). Joong Bok Ahn collaborates with scholars based in South Korea. Joong Bok Ahn's co-authors include Hong Woo Lee, Soon Kil Ahn, Sung Kwon Kang, Bok Young Kim, Chung Il Hong, Jae Soo Shin, Byoung Chan Kim, H LEE, Sook Young Yoon and Steven Lee and has published in prestigious journals such as European Journal of Medicinal Chemistry, Chemical and Pharmaceutical Bulletin and Organic Process Research & Development.

In The Last Decade

Joong Bok Ahn

9 papers receiving 357 citations

Peers

Joong Bok Ahn
T. David Pallin United Kingdom
Brenda Mihan United States
Xiaoxia Qian United States
Tamara Dejneka United States
Narendra Panday Switzerland
Pratik Devasthale United States
Dulce Garrido United States
Jill Nunez Switzerland
C. J. F. BICHARD United Kingdom
T. David Pallin United Kingdom
Joong Bok Ahn
Citations per year, relative to Joong Bok Ahn Joong Bok Ahn (= 1×) peers T. David Pallin

Countries citing papers authored by Joong Bok Ahn

Since Specialization
Citations

This map shows the geographic impact of Joong Bok Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joong Bok Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joong Bok Ahn more than expected).

Fields of papers citing papers by Joong Bok Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joong Bok Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joong Bok Ahn. The network helps show where Joong Bok Ahn may publish in the future.

Co-authorship network of co-authors of Joong Bok Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Joong Bok Ahn. A scholar is included among the top collaborators of Joong Bok Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joong Bok Ahn. Joong Bok Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lee, Hong Woo, Joong Bok Ahn, Sung Kwon Kang, Soon Kil Ahn, & Deok-Chan Ha. (2007). Process Development and Scale-Up of PPAR α/γ Dual Agonist Lobeglitazone Sulfate (CKD-501). Organic Process Research & Development. 11(2). 190–199. 27 indexed citations
2.
Lee, Hong Woo, Joong Bok Ahn, Jung Hwa Lee, et al.. (2006). Selective N-Demethylation of Tertiary Aminofumagillols with Selenium Dioxide via a Non-classical Polonovski Type Reaction. Heterocycles. 68(5). 915–915. 3 indexed citations
3.
Lee, Hong Woo, Bok Young Kim, Joong Bok Ahn, et al.. (2006). Molecular Design, Synthesis, and Hypoglycemic and Hypolipidemic Activities of Novel Pyrimidine Derivatives Having Thiazolidinedione.. ChemInform. 37(7). 11 indexed citations
4.
LEE, H, Byoung Chan Kim, Joong Bok Ahn, et al.. (2005). Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione. European Journal of Medicinal Chemistry. 40(9). 862–874. 155 indexed citations
5.
Lee, Hong Woo, Joong Bok Ahn, Jung Hwa Lee, et al.. (2005). Selective Reduction of Nitrocinnamoylfumagillols with α,β-Unsaturated Ester Using Borohydride Exchange Resin (BER)-Nickel Acetate. Heterocycles. 65(8). 1843–1843. 6 indexed citations
6.
Kim, Bok Young, Joong Bok Ahn, Hong Woo Lee, et al.. (2004). Synthesis and biological activity of novel substituted pyridines and purines containing 2,4-thiazolidinedione. European Journal of Medicinal Chemistry. 39(5). 433–447. 146 indexed citations
7.
Lee, Hong Woo, Bok Young Kim, Joong Bok Ahn, et al.. (2003). Hantzsch Dihydropyridine: An Effective and Convenient Regioselective Reducing Agent for 5‐Benzylidene‐2,4‐thiazolidinedione Derivatives.. ChemInform. 34(6). 1 indexed citations
8.
Kim, Bok Young, Joong Bok Ahn, Hong Woo Lee, et al.. (2003). Synthesis and Antihyperglycemic Activity of Erythrose, Ribose and Substituted Pyrrolidine Containing Thiazolidinedione Derivatives. Chemical and Pharmaceutical Bulletin. 51(3). 276–285. 14 indexed citations
9.
Lee, Hong Woo, Bok Young Kim, Joong Bok Ahn, et al.. (2002). Hantzsch Dihydropyridine: An Effective and Convenient Regioselective Reducing Agent for the 5-Benzylidene-2,4-thiazolidinedione Derivatives. Heterocycles. 57(11). 2163–2163. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026